Chicory Root Fiber Constipation Randomized Trial Evidence Table

Structured evidence table for Chicory Root Fiber Constipation Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Chicory Root Fiber Constipation Randomized TrialClinically, chRG-I was well-tolerated and slightly improved stool consistency compared to placebo.4Kerezoudi EN (2026)Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
Chicory Root Fiber Constipation Randomized TrialIn an intestinal barrier challenge model, chRG-I fermentates (a pool of metabolites including SCFA and fragments of chRG-I) protected barrier integrity, modulated the cytokine milieu away from a predominantly pro-inflammatory response, as characterized by increased IL4 and IL22 and reduced IL9, IL17A, and IL21.4Kerezoudi EN (2026)Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
Chicory Root Fiber Constipation Randomized TrialConclusion: Supplementation with a low dose of chRG-I is well-tolerated, beneficially modulates the gut microbiome - which can protect the intestinal barrier, and subtly enhances systemic immune readiness, suggesting that chRG-I may have benefits as a functional food ingredient.4Kerezoudi EN (2026)Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
Chicory Root Fiber Constipation Randomized TrialBackground: Pectic rhamnogalacturonan-I (RG-I) is a dietary fiber that modulates the gut-immune axis.4Kerezoudi EN (2026)Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
Chicory Root Fiber Constipation Randomized TrialBackground Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden.4Teterovska R (2025)Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.
Chicory Root Fiber Constipation Randomized TrialDiscrepancies between product information and available scientific evidence highlight regulatory and consumer protection challenges.4Teterovska R (2025)Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.
Chicory Root Fiber Constipation Randomized TrialConventional therapies may have limited efficacy or undesirable side effects, underscoring the need for safe complementary approaches.4Teterovska R (2025)Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.
topicChicory Root Fiber Constipation Randomized Trial
claimClinically, chRG-I was well-tolerated and slightly improved stool consistency compared to placebo.
evidence level4
citationKerezoudi EN (2026)
sourceDietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
topicChicory Root Fiber Constipation Randomized Trial
claimIn an intestinal barrier challenge model, chRG-I fermentates (a pool of metabolites including SCFA and fragments of chRG-I) protected barrier integrity, modulated the cytokine milieu away from a predominantly pro-inflammatory response, as characterized by increased IL4 and IL22 and reduced IL9, IL17A, and IL21.
evidence level4
citationKerezoudi EN (2026)
sourceDietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
topicChicory Root Fiber Constipation Randomized Trial
claimConclusion: Supplementation with a low dose of chRG-I is well-tolerated, beneficially modulates the gut microbiome - which can protect the intestinal barrier, and subtly enhances systemic immune readiness, suggesting that chRG-I may have benefits as a functional food ingredient.
evidence level4
citationKerezoudi EN (2026)
sourceDietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
topicChicory Root Fiber Constipation Randomized Trial
claimBackground: Pectic rhamnogalacturonan-I (RG-I) is a dietary fiber that modulates the gut-immune axis.
evidence level4
citationKerezoudi EN (2026)
sourceDietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
topicChicory Root Fiber Constipation Randomized Trial
claimBackground Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden.
evidence level4
citationTeterovska R (2025)
sourceMedicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.
topicChicory Root Fiber Constipation Randomized Trial
claimDiscrepancies between product information and available scientific evidence highlight regulatory and consumer protection challenges.
evidence level4
citationTeterovska R (2025)
sourceMedicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.
topicChicory Root Fiber Constipation Randomized Trial
claimConventional therapies may have limited efficacy or undesirable side effects, underscoring the need for safe complementary approaches.
evidence level4
citationTeterovska R (2025)
sourceMedicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.

Source documents

  1. Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.
  2. Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.